PADIGLIONI, SONIA
 Distribuzione geografica
Continente #
NA - Nord America 758
EU - Europa 440
AS - Asia 185
SA - Sud America 1
Totale 1.384
Nazione #
US - Stati Uniti d'America 753
IT - Italia 109
IE - Irlanda 98
SE - Svezia 92
RU - Federazione Russa 74
HK - Hong Kong 58
CN - Cina 46
SG - Singapore 42
DE - Germania 27
JO - Giordania 26
GB - Regno Unito 11
CH - Svizzera 6
FI - Finlandia 6
IN - India 5
KR - Corea 5
CA - Canada 4
ES - Italia 4
CZ - Repubblica Ceca 2
FR - Francia 2
AZ - Azerbaigian 1
BE - Belgio 1
BG - Bulgaria 1
BR - Brasile 1
DK - Danimarca 1
GR - Grecia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
NL - Olanda 1
PA - Panama 1
PL - Polonia 1
PT - Portogallo 1
UA - Ucraina 1
Totale 1.384
Città #
Chandler 126
Fairfield 105
Dublin 98
Ashburn 69
Seattle 55
Woodbridge 42
Houston 41
Hong Kong 38
Cambridge 31
Altamura 29
Lawrence 28
Wilmington 28
Moscow 27
Bremen 23
Singapore 22
Florence 20
Shanghai 17
Princeton 15
Buffalo 14
New York 12
Beijing 11
Ann Arbor 10
Kent 9
Medford 9
West Jordan 8
Boston 7
Bern 6
Helsinki 6
Dearborn 5
Los Angeles 5
Seoul 5
Arezzo 4
Boardman 4
Pune 4
Toronto 4
Como 3
Duncan 3
Falls Church 3
Kunming 3
London 3
Norwalk 3
San Diego 3
Casamarciano 2
Colle di Val d'Elsa 2
Dallas 2
Guangzhou 2
Manchester 2
Monza 2
Naples 2
Pisa 2
Poggibonsi 2
Prescot 2
Andover 1
Athens 1
Bagno A Ripoli 1
Baku 1
Barcelona 1
Bitola 1
Bologna 1
Brentford 1
Brussels 1
Böblingen 1
Chennai 1
Copenhagen 1
Fiesole 1
Fuzhou 1
Hebei 1
Hillsboro 1
Hounslow 1
Kilburn 1
Kumamoto 1
Laurel 1
Lisbon 1
Lucca 1
Madrid 1
Milan 1
Nanchang 1
Nantong 1
Napoli 1
Osimo 1
Palermo 1
Panama City 1
Pinerolo 1
Prague 1
Redwood City 1
Rio de Janeiro 1
Rome 1
Serra 1
Shenyang 1
Simone 1
Soave 1
Sofia 1
Trieste 1
Warsaw 1
Washington 1
Wuhan 1
Totale 1.022
Nome #
The implication of BDNF Val66Met polymorphism in progression from subjective cognitive decline to mild cognitive impairment and Alzheimer's disease: a 9-year follow-up study 107
From Subjective Cognitive Decline to Alzheimer's Disease: The Predictive Role of Neuropsychological Assessment, Personality Traits, and Cognitive Reserve. A 7-Year Follow-Up Study 97
KIBRA T allele influences memory performance and progression of cognitive decline: a 7-year follow-up study in subjective cognitive decline and mild cognitive impairment 94
The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study 83
Crossed aphasia in nonfluent variant of primary progressive aphasia carrying a GRN mutation 80
A case of limbic encephalitis evolving into a frontotemporal dementia-like picture 79
Assessing the effectiveness of subjective cognitive decline plus criteria in predicting the progression to Alzheimer’s disease: an 11-year follow-up study 78
Crossed aphasia confirmed by fMRI in a case with nonfluent variant of primary progressive aphasia carrying a GRN mutation 75
Early functional MRI changes in a prodromal semantic variant of primary progressive aphasia: a longitudinal case report 65
Influence of apoe genotype and clock t3111c interaction with cardiovascular risk factors on the progression to alzheimer’s disease in subjective cognitive decline and mild cognitive impairment patients 58
Challenges in Alzheimer's Disease Diagnostic Work-Up: Amyloid Biomarker Incongruences 56
Matching clinical diagnosis and amyloid biomarkers in alzheimer’s disease and frontotemporal dementia 47
Alzheimer's Disease CSF Biomarker Profiles in Idiopathic Normal Pressure Hydrocephalus 46
Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia 45
Per2 C111G polymorphism influences cognition in Subjective Cognitive Decline and Mild Cognitive Impairment. A 10-year follow-up study 44
Dual Effect of PER2 C111G Polymorphism on Cognitive Functions across Progression from Subjective Cognitive Decline to Mild Cognitive Impairment 37
Huntingtin gene intermediate alleles influence the progression from subjective cognitive decline to mild cognitive impairment: A 14-year follow-up study 36
CAG Repeats Within the Non-pathological Range in the HTT Gene Influence Personality Traits in Patients With Subjective Cognitive Decline: A 13-Year Follow-Up Study 35
The effect of cag repeats within the non-pathological range in the htt gene on cognitive functions in patients with subjective cognitive decline and mild cognitive impairment 33
Plasma neurofilament light chain as a biomarker of Alzheimer's disease in Subjective Cognitive Decline and Mild Cognitive Impairment 31
Loss of speech and functional impairment in Alzheimer's disease-related primary progressive aphasia: predictive factors of decline 30
Gender differences in cognitive reserve: implication for subjective cognitive decline in women 30
Differences and Similarities in Empathy Deficit and Its Neural Basis between Logopenic and Amnesic Alzheimer's Disease 28
Unravelling neural correlates of empathy deficits in Subjective Cognitive Decline, Mild Cognitive Impairment and Alzheimer's Disease 24
Disentangling empathy impairment along Alzheimer's disease continuum: From subjective cognitive decline to Alzheimer's dementia 20
Regional analysis of the magnetization transfer ratio of the brain in mild Alzheimer disease and amnestic mild cognitive impairment 11
PRedicting the EVolution of SubjectIvE Cognitive Decline to Alzheimer’s Disease With machine learning: the PREVIEW study protocol 9
Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns 9
The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment 7
Plasma neurofilament light chain predicts Alzheimer's disease in patients with subjective cognitive decline and mild cognitive impairment: A cross-sectional and longitudinal study 7
Degradation of EEG microstates patterns in subjective cognitive decline and mild cognitive impairment: Early biomarkers along the Alzheimer’s Disease continuum? 4
Plasma p-tau181 as a promising non-invasive biomarker of Alzheimer's Disease pathology in Subjective Cognitive Decline and Mild Cognitive Impairment 4
Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD 4
Do Cholinesterase Inhibitors Act Primarily on Attention Deficit? A Naturalistic Study in Alzheimer's Disease Patients 3
Totale 1.416
Categoria #
all - tutte 8.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020214 0 15 3 10 34 28 30 25 24 19 18 8
2020/2021129 13 9 2 22 8 6 4 11 23 8 13 10
2021/202299 5 1 7 4 2 7 0 13 4 5 18 33
2022/2023548 58 113 37 41 35 88 61 27 68 1 11 8
2023/2024299 5 23 25 11 18 38 21 68 7 44 22 17
2024/2025104 69 35 0 0 0 0 0 0 0 0 0 0
Totale 1.416